Moreover, TGF-β1 and NCK1-AS1 overexpression increased ESCC cell migration and invasion, while TGF-β inhibitor reduced the effects of NCK1-AS1 overexpression. The gene discussed is TGFB1; the disease is esophageal squamous cell carcinoma.